Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.23 - $0.35 $140 - $214
-613 Reduced 1.39%
43,583 $10,000
Q4 2023

Feb 14, 2024

BUY
$0.21 - $0.36 $80 - $138
385 Added 0.88%
44,196 $14,000
Q3 2023

Nov 16, 2023

BUY
$0.26 - $0.61 $2,600 - $6,100
10,000 Added 29.58%
43,811 $11,000
Q1 2023

May 15, 2023

BUY
$0.36 - $1.0 $260 - $723
723 Added 2.19%
33,811 $22,000
Q4 2022

Feb 10, 2023

BUY
$0.29 - $0.47 $2,922 - $4,736
10,077 Added 43.79%
33,088 $11,000
Q2 2022

Aug 15, 2022

BUY
$0.37 - $0.61 $1,850 - $3,050
5,000 Added 27.76%
23,011 $9,000
Q1 2022

May 16, 2022

BUY
$0.53 - $1.19 $9,545 - $21,433
18,011 New
18,011 $11,000
Q2 2021

Aug 04, 2021

SELL
$1.52 - $3.62 $176,177 - $419,579
-115,906 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$0.9 - $6.32 $104,315 - $732,525
115,906 New
115,906 $377,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.